Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Massachusetts Legislature Approves the PROTECT Act, Creating Among the Strongest Protections in the Nation
Massachusetts House of Representatives
Today the Massachusetts Legislature passed sweeping legislation to protect residents from overreach by federal immigration authorities and to ensure that local and state law enforcement are not involved in federal immigration enforcement.
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire, Inc.
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and...
Cabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant
GlobeNewswire, Inc.
BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced a modified $50 million grant from the U.S. Department of Energy’s (DOE) Office of Critical Minerals and Energy Innovation (CMEI) that will support the...
Boston Announces Youth Grants For Climate Resilience Projects As Part Of the Bloomberg Philanthropies Youth Climate Action Fund
City of Boston
Applications are now open for microgrants supporting initiatives aligned with Boston’s 2030 Climate Action Plan The City of Boston announced that Boston youth can help shape innovative climate resilience solutions through the City’s participation...
Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease
GlobeNewswire, Inc.
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Rezera Inc. (the “Company”), a clinical-stage biotechnology company developing a portfolio of internally-invented and wholly-owned oral inhibitors of NLRP3 to address inflammatory drivers of...
Massachusetts Senate Opens New Path for Norwood Hospital
Massachusetts Senate
Senate Steps Up to Aid Residents Who Were Failed by Steward Health Care and Medical Properties Trust (BOSTON—7/29/2026) The Massachusetts Senate took action today to protect the health and safety of Norfolk County and Greater Boston residents by...
Wearable Healthcare Devices Market to Grow from USD 45.29 Billion in 2025 to USD 75.98 Billion by 2030, at a CAGR of 10.9% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Aug. 14, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global wearable healthcare devices market will grow from USD 45.29 billion in 2025 to USD 75.98 billion by 2030, at a CAGR of 10.9% during the forecast period....
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire, Inc.
Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of...
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…
GlobeNewswire, Inc.
BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that...
Executive Home Care Northeast Greater Boston Helps Families Navigate In-Home Care Decisions
EIN Presswire
Individualized care plans, thoroughly screened caregivers, and flexible support options help local families care for aging and disabled loved ones.
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
GlobeNewswire, Inc.
Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its...
Radiant Laser MD Opens Second Location Near Boston University and Fenway
EIN Presswire
Physician-led laser hair removal practice brings Candela GentleMax Pro® technology and flexible, pay-as-you-go pricing to Boston BOSTON, MA, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- Radiant Laser MD, a physician-led practice...
Interra Health Named on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
GlobeNewswire, Inc.
BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Interra Health, which delivers the first patient-centric medication prescribing experience, announced today that it has been named on the 2026 Inc. 5000 list, the annual list of the fastest-growing private...
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
GlobeNewswire, Inc.
MIAMI, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the expansion of its financing relationship with HealthCare Royalty, a business of KKR (HCRx), through the issuance of an additional $125 million...
The Health Care Transformation Task Force Welcomes Two New Members
EIN Presswire
WASHINGTON, DC, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- The Health Care Transformation Task Force is pleased to welcome Inflection Medicine and the National Kidney Foundation (NKF) as its newest members.
Reese Consumer Health Acquires Topical Pain Relief Brand Australian Dream
GlobeNewswire, Inc.
CLEVELAND, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Reese Consumer Health today announced the acquisition of Australian Dream, a nationally recognized consumer health brand specializing in topical pain relief for arthritis, muscle, and joint discomfort....
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
GlobeNewswire, Inc.
FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the devastating, irreversible neurologic progression and loss of function associated with Sanfilippo syndrome Type A Ultragenyx’s UltraCare® program...
Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
GlobeNewswire, Inc.
New Drug Application for azetukalner in focal seizures submitted to U.S. Food and Drug Administration; X-TOLE3 and X-ACKT continue to enroll focal seizure and PGTCS patients, respectively Enrollment in X-NOVA2 study in MDD completed with...
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026 Long-term Phase 2 BESTOW data presented at ATC 2026 demonstrated sustained higher...
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCV C-FORWARD Phase 3 Trial Outside North America on...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.